Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of Progenity, Inc. n/k/a Biora Therapeutics, Inc. common stock - BIORQ
Glancy Prongay & Murray LLP Announces the Proposed Class Action Settlement on Behalf of Purchasers of Progenity, Inc. n/k/a Biora Therapeutics, Inc. common stock - BIORQ |
| [08-December-2025] |
SAN DIEGO, Dec. 8, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that the United States District Court for the Southern District of California has approved the following announcement of a proposed securities class action settlement that would benefit purchasers of Progenity, Inc. n/k/a Biora Therapeutics, Inc. common stock (OTCMKTS: BIORQ). SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION, CERTIFICATION OF SETTLEMENT CLASS, AND PROPOSED SETTLEMENT; (II) SETTLEMENT FAIRNESS HEARING; AND (III) MOTION FOR AN AWARD OF ATTORNEYS' FEES TO: All persons and entities that purchased or otherwise acquired the common stock of Progenity, Inc. (n/k/a Biora Therapeutics, Inc.) pursuant and/or traceable to Progenity's initial public offering Registration Statement (i.e., from June 18, 2020 through December 2, 2020, both dates inclusive), and were damaged thereby (the "Settlement Class")1: PLEASE READ THIS NOTICE CAREFULLY, YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT. YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Southern District of California, that the above-captioned litigation (the "Action") has been certified as a class action on behalf of the Settlement Class, except for certain persons and entities who are excluded from the Settlement Class by definition as set forth in the Notice of (I) Pendency of Class Action, Certification of Settlement Class, and Proposed Settlement; (II) Settlement Fairness Hearing; and (III) Motion for an Award of Attorneys' Fees and Reimbursement of Litigation Expenses (the "Notice"). YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action have reached a proposed settlement of the Action for $1,000,000 in cash (the "Settlement"), that, if approved, will resolve all claims in the Action. A hearing will be held on February 23, 2026 at 10:00 a.m., before the Honorable Ruth Bermudez Montenegro in Courtroom 5B of the Edward J. Schwartz United States Courthouse, 221 West Broadway, San Diego, CA 92101, to determine (i) whether the proposed Settlement should be approved as fair, reasonable, and adequate; (ii) whether the Action should be dismissed with prejudice against Defendants, and the Releases specified and described in the Stipulation (and in the Notice) should be granted; (iii) whether the proposed Plan of Allocation should be approved as fair and reasonable; and (iv) whether Lead Counsel's application for an award of attorneys' fees and reimbursement of expenses should be approved. If you are a member of the Settlement Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Settlement Fund. The Notice and Proof of Claim and Release Form ("Claim Form"), can be downloaded from the website maintained by the Claims Administrator, www.strategicclaims.net/progenity. You may also obtain copies of the Notice and Claim Form by contacting the Claims Administrator at In re Progenity Inc. Securities Litigation, c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson St., Ste. 205, Media, PA 19063, 1-866-274-4004, info@strategicclaims.net. If you are a member of the Settlement Class, in order to be eligible to receive a payment under the proposed Settlement, you must submit a Claim Form to the Claims Administrator postmarked at the address above or online at www.strategicclaims.net/progenity no later than February 3, 2026. If you are a Settlement Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement but you will nevertheless be bound by any judgments or orders entered by the Court in the Action. If you are a member of the Settlement Class and wish to exclude yourself from the Settlement Class, you must submit a request for exclusion such that it is received no later than February 3, 2026, in accordance with the instructions set forth in the Notice. If you properly exclude yourself from the Settlement Class, you will not be bound by any judgments or orders entered by the Court in the Action and you will not be eligible to share in the proceeds of the Settlement. Any objections to the proposed Settlement, the proposed Plan of Allocation, or Lead Counsel's motion for attorneys' fees and reimbursement of Litigation Expenses, must be filed with the Court and delivered to Lead Counsel and Defendants' Counsel such that they are received no later than February 3, 2026, in accordance with the instructions set forth in the Notice. Please do not contact the Court, the Clerk's office, Progenity (n/k/a Biora Therapeutics, Inc.), or its counsel regarding this notice. All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator. Inquiries, other than requests for the Notice and Claim Form, should be made to Lead Counsel: GLANCY PRONGAY & MURRAY LLP Requests for the Notice and Claim Form should be made to: In re Progenity Inc. Securities Litigation By Order of the Court 1 All capitalized terms used in this Summary Notice that are not otherwise defined herein have the meanings ascribed to them in the Stipulation and Agreement of Settlement dated May 7, 2025 (the "Stipulation"), which is available at www.strategicclaims.net/progenity. SOURCE Glancy Prongay & Murray LLP | ||
Company Codes: OTC-BB:BIORQ,OTC-PINK:BIORQ |
View original content:Breaking News: National Junior College/Prep Football League Launches to Empower High School Athletes On and Off the Field
